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Since its first description in 2000, CTX-M-14 has become one of the most widespread extended-spectrum
-lactamases in Spain. In the present Escherichia coli multilevel population genetic study involving the
characterization of phylogroups, clones, plasmids, and genetic platforms, 61 isolates from 16 hospitalized
patients and 40 outpatients and healthy volunteers recovered from 2000 to 2005 were analyzed. Clonal
relatedness (XbaI pulsed-field gel electrophoresis [PFGE] type, phylogenetic group, multilocus sequence type
[MLST]) was established by standard methods. Analysis of transferred plasmids (I-CeuI; S1 nuclease; re-
striction fragment length polymorphism analysis; and analysis of RNA interference, replicase, and relaxase)
was performed by PCR, sequencing, and hybridization. The genetic environment of blaCTX-M-14 was charac-
terized by PCR on the basis of known associated structures (ISEcp1, IS903, ISCR1). The isolates were mainly
recovered from patients in the community (73.8%; 45/61) with urinary tract infections (62.2%; 28/45). They
were clonally unrelated by PFGE and corresponded to phylogenetic groups A (36.1%), D (34.4%), and B1
(29.5%). MLST revealed a high degree of sequence type (ST) diversity among phylogroup D isolates and the
overrepresentation of the ST10 complex among phylogroup A isolates and ST359/ST155 among phylogroup B1
isolates. Two variants of blaCTX-M-14 previously designated blaCTX-M-14a (n 59/61) and blaCTX-M-14b (n 2/61)
were detected. blaCTX-M-14a was associated with either ISEcp1 within IncK plasmids (n  27), ISCR1 linked to
an IncHI2 plasmid (n  1), or ISCR1 linked to IncI-like plasmids (n  3). The blaCTX-M-14b identified was
associated with an ISCR1 element located in an IncHI2 plasmid (n  1) or with ISEcp1 located in IncK (n 
1). The CTX-M-14-producing E. coli isolates in our geographic area are frequent causes of community-acquired
urinary tract infections. The increase in the incidence of such isolates is mostly due to the dissemination of
IncK plasmids among E. coli isolates of phylogroups A, B1, and D.
Since their first description in the late 1980s, plasmid-medi-
ated CTX-M extended-spectrum -lactamases (ESBLs) have
increasingly been reported worldwide in both hospital and
community settings and have mainly been associated with
Escherichia coli isolates, which often cause urinary tract infec-
tions (UTIs) (7, 46, 48, 56). The CTX-M enzymes are classified
into five groups on the basis of their amino acid sequences, and
of these, the CTX-M-1 and CTX-M-9 clusters have been the
most frequently reported worldwide (7).
The CTX-M-14 enzyme is, besides CTX-M-9, the most
widespread enzyme of the CTX-M-9 group. It was initially
identified among Shigella clinical isolates from Korea in 1995
(45); and it is now globally disseminated, being endemic in
Spain, France, Portugal, the United Kingdom, Korea, China,
Hong Kong, Taiwan, Thailand, Japan, Canada, and the United
States (9, 22, 23, 25, 26, 32–34, 36, 38, 46, 49, 56). Although
specific strains have caused community outbreaks in Canada
and Japan (38, 46, 49), an apparently high degree of clonal
diversity of CTX-M-14-producing E. coli isolates is described
in most of the studies (9, 23, 32, 33, 38, 45, 46). The dissemi-
nation of blaCTX-M-14 via plasmids has also been reported (15,
38, 39).
The blaCTX-M-14 enzyme is thought to be the precursor of
the CTX-M-9 cluster, and several times it seems to have been
mobilized from Kluyvera chromosomes to plasmids (4). Analy-
sis of specific isolates identified two variants of blaCTX-M-14 on
genetic platforms containing either ISEcp1 or ISCR1 se-
quences, highlighting the different pathways for the acquisition
and evolution of this gene (2, 4, 17, 39). Hitherto, studies
describing the occurrence of this ESBL have analyzed only a
limited number of isolates at the molecular level. However, a
comprehensive multilevel analysis of the whole genetic context
in areas of endemicity, including a full description of the E. coli
phylogenetic groups, clones, plasmids, and genetic platforms
involved in the dissemination of blaCTX-M-14, has not been
performed.
CTX-M-14, initially detected in 2000 in Spain, constitutes
one of the most prevalent CTX-M enzymes in that country and
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is recovered from hospitalized patients, healthy humans, ani-
mals, and environmental samples (5, 12, 22, 53, 54). In the
work described here, we analyzed the epidemiological features
and multilevel genetic diversity of CTX-M-14-producing or-
ganisms from humans with and without hospital exposure to
obtain a better understanding of their recent widespread ap-
pearance and persistence in our geographic area.
MATERIALS AND METHODS
Bacterial strains. We studied 61 CTX-M-14-producing E. coli isolates from 56
individuals living in a suburban area of Madrid, Spain, from 2000 to 2005. They
were mainly community-based persons (n  40 [71.4%]) comprising 2 healthy
volunteers without previous antibiotic or hospital exposure (53), 3 cohabitants of
patients with UTIs caused by CTX-M-14 recovered within 2 weeks of the case
detection (54), and 35 outpatients. The hospitalized patients were located in
medical wards (n  13 [23.2%]), intensive care units (ICUs; n  2 [3.6%]), or
surgical wards (n  1 [1.8%]) (Table 1). The sample represents all CTX-M-14-
producing isolates recovered in the Hospital Universitario Ramo´n y Cajal (39
from urine, 1 from blood, 1 from wound, and 2 from feces) and fecal isolates
from two surveillance studies performed in the same city during the same time
period (53, 54).
One isolate per patient (or more than one per patient, if different antibiotic
resistance patterns were detected in isolates from the same sample or if they
showed different PFGE patterns) was selected for further analysis. Bacterial
identification and antibiotic susceptibility testing were performed with the semi-
automated Wider system (Fco. Soria Melguizo, Madrid, Spain). Analysis of the
susceptibilities of the isolates to non-ß-lactam antibiotics was performed by the
disk diffusion method according to CLSI guidelines (11). The CLSI breakpoints
for netilmicin were used for apramycin. Strains showing intermediate suscepti-
bility were considered resistant.
Clonal relatedness. Clonal relatedness was established by pulsed-field gel
electrophoresis (PFGE) of XbaI-digested genomic DNA in a CHEF-DRIII
device (Bio-Rad, La Jolla, CA) by using electrophoresis conditions of 14°C, 6
V/cm2, 10 to 40 s, and 24 h; standard procedures and criteria were followed (41).
The assignation of E. coli phylogenetic groups was carried out by the multiplex
PCR assay previously described by Clermont et al. (10). Representative E. coli
isolates mainly belonging to phylogroups A and B1 were further characterized by
multilocus sequence typing (MLST) by using the standard seven housekeeping
loci (http://www.mlst.net). The fumC genes of E. coli isolates belonging to the D
phylogroup were analyzed for the presence of a single nucleotide polymorphism
(C288T), which is a specific marker for E. coli “clonal group A.” This clone is
disseminated worldwide, it belongs to sequence type 69 (ST69), and it is respon-
sible for community UTIs (50).
MLST data were analyzed by using the eBURST program (version 3; http:
//eburst.mlst.net), which assesses the relationship within clonal complexes. The
entire E. coli MLST database (2,255 isolates and 1,065 STs; last update, June
2009) was considered.
Transferability and location of blaCTX-M-14 gene. Transfer was tested by broth
and filter mating assays with E. coli K-12 strain BM21R (nalidixic acid and
rifampin [rifampicin] resistant, lactose fermentation positive, and plasmid free)
as the recipient for 6 to 12 h at 30°C and 37°C. Transconjugants were selected on
Luria-Bertani agar plates supplemented with cefotaxime (2 mg/liter) and ri-
fampin (100 mg/liter) and were incubated at 37°C for 24 h.
The chromosomal and/or plasmid location of blaCTX-M-14 genes was assessed
by the hybridization of I-CeuI-digested genomic DNA with blaCTX-M-14 and 16S
rRNA gene probes by using the following electrophoresis conditions: 5 to 25 s for
23 h and 60 to 120 s for 10 h, 14°C, and 6 V/cm2 (41). Transfer and hybridization
were performed by standard procedures. Labeling and detection were carried out
with an AlkPhos commercial kit, according to the manufacturer’s instructions
(Amersham Life Sciences, Uppsala, Sweden).
Plasmid characterization. Plasmid DNA was obtained by using a QIAgen
plasmid midikit (Qiagen, Hilden, Germany). Plasmids were preliminarily classi-
TABLE 1. CTX-M-14-producing E. coli strains (2001 to 2005)
Sample Phylogenetic group Patient ward or origin Origin MLSTa
Clinical (n  42) A (n  13) Medical (n  4) Urine (n  3) ST10 complex (ST617, n  1), ST23 complex
(n  2)
Blood (n  1) ST168 complex (ST93, n  1)
Outpatient (n  9) Urine (n  9) ST10 complex (n  3, two of ST617 and one of
ST167), ST350 (n  1), ST155 complex
(ST58, n  1), ST1014 (n  1)
B1 (n  14) Medical (n  3) Urine (n  3) ST359 (n  2)
ICU (n  1) Urine (n  1) ST155 complex (ST1015, n  1)
Surgical (n  1) Wound (n  1)
Outpatient (n  9) Urine (n  9) ST359 (n  5), ST155 complex (n  2, ST58
and ST1017)
D (n  15) Medical (n  4) Urine (n  4) ST117 (n  1), fumC4 (n  1), fumC31 (n  2)
ICU (n  1) Urine (n  1)
Outpatient (n  10) Urine (n  9), ST31 complex (n  1, ST393), ST770 (n  1),
ST1019 (n  1), fumC4 (n  2), fumC31
(n  1), fumC40 (n  1), fumC45 (n  2)
Wound (n  1) ST624 (n  1)
Fecal (n  19) A (n  9) Medical (n  1) ST10 complex (ST10, n  1)
Outpatient (n  8) ST10 complex (n  7; 5 ST10, 1 ST48, 1
ST167), ST168 complex (ST93, n  1)
B1 (n  4) Medical (n  1)
Outpatient (n  3) ST155 complex (ST1018, n  1)
D (n  6) Outpatient (n  6) ST69 complex (ST106, n  1), ST59 (n  1),
fumC31 (n  1), fumC32 (n  1), fumC39
(n  1), fumC40 (n  1)
a MLST was performed with a selected group of isolates (n  37); amplification of fumC was performed for all isolates of phylogroup D. Isolates belonging
to either phylogroup A or phylogroup B1 were associated with the ST155 clonal complex. Discrepancies among MLSTs and phylogroups have been described
previously (20, 55).
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fied according to their incompatibility group by using the PCR-based replicon-
typing (PBRT) scheme described by Carattoli et al. (8). Plasmid size and content
were determined by hybridization of S1 nuclease-digested genomic DNA (41)
with probes specific for blaCTX-M-14. Confirmation of the replicon content was
also undertaken by hybridization of PstI-digested plasmid DNA with probes
specific for both blaCTX-M-14 and rep amplified by PCR from different samples.
The relationship among plasmids was determined by comparison of their DNA
patterns generated after digestion with the EcoRI, PstI, and HpaI enzymes and
electrophoresis in 1% agarose at 100 V for 4 h.
Plasmids preliminarily classified as members of the IncI complex (those that
yielded an amplification product by using primers specific for incompatibility
group I (IncI), IncK, and/or IncB/O by the PBRT method) were further studied
(8). We analyzed the sequences corresponding to RNA interference (RNAi; also
named inc, which encodes a segment of RNA of approximately 70 bp that
regulates replication by repressing the expression of the replicase gene) and also
to the replication and the relaxase proteins of a subset of representative isolates.
Identification of RNAi was performed by analysis of the amplicons obtained by
the PBRT method. Identification of the replication proteins was carried out by
analysis of the PCR products obtained with primers RNAI (5-ATGCGCCAT
AAGGCATTCA-3) and REPZA (5-AGTCGC TTCAGATGGTCAT-3) and
an amplification protocol consisting of 1 cycle at 94°C for 5 min and 35 cycles at
94°C for 1 min, 54°C for 1 min, and 72°C for 2 min, followed by a final step at
72°C for 10 min. Identification of plasmid relaxases was performed by PCR with
primers MOBP12 forward (5-GCAAAAGATGACACTGAYCCYGTTTT-3)
and MOBP12 reverse (5-AGCGATGTGGATGTGAAGGTTATCHGTRTC-
3) and conditions of 30 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 30 s.
The amplified DNA segments were then sequenced in both orientations (1, 19).
Analysis of blaCTX-M-14 genetic environment. As blaCTX-M-14 has been found to
be associated with different genetic environments, we tested for the presence of
sequences associated with known genetic platforms: ISEcp1, IS903, intI1, and
ISCR1 (2, 17, 39). Oligonucleotides corresponding to different regions of ISEcp1
and IS903 were used in order to detect elements containing ISEcp1 and/or
IS903, as described previously (17). The link of class 1 integrons containing
blaCTX-M-14 to Tn21-like transposons was screened for by PCR mapping with the
primers and conditions previously described (41).
Nucleotide sequence accession numbers. The sequences corresponding to the
plasmids described in this paper were assigned the indicated GenBank (NCBI)
accession numbers: pRYC105, GQ892052; pRYC106, GQ892053; pRYC109,
GQ892054; pRYC110, GQ892050 and GQ892051.
RESULTS AND DISCUSSION
E. coli isolates producing CTX-M-14 belong to phylogroups
A, B1, and D and are mostly associated with UTIs. The 61
CTX-M-14-producing isolates included in this study were clas-
sified into 60 different PFGE patterns and were similarly dis-
tributed among phylogenetic groups A, D, and B1 (22, 21, and
18 isolates, respectively, representing 36.1%, 34.4%, and
29.5% of the isolates included in the study, respectively). Most
of the CTX-M-14-producing E. coli strains of phylogroups A
and B1 belonged to particular clonal complexes; phylogroup A
isolates clustered in the ST10 complex (12/18 of the isolates
analyzed) and also in the ST168 complex (2/18) or the ST23
complex (2/18), while phylogroup B1 isolates grouped either in
the ST359 complex (7/12) or the ST155 complex (5/12). Anal-
ysis of the fumC sequences from E. coli isolates belonging to
phylogroup D showed a high degree of diversity (Table 1). One
strain with the C288T single polymorphism specific for uro-
pathogenic E. coli (UPEC) clonal group A (CGA) was identi-
fied as ST106, which fits within the ST69 clonal complex. The
other isolates studied corresponded to ST59, ST117, ST393,
ST624, ST770, and ST1019 (Fig. 1; Table 1).
The isolates studied were frequently associated with UTIs
(n  39, 64%) and were resistant to nalidixic acid (73.8%;
FIG. 1. Snapshot of clusters of E. coli populations from the E. coli MLST database with related and unrelated STs. The STs identified in this
study are represented by circles: dark gray circles, founders of each clonal complex; light gray circles, subgroups of the founder; and black circles,
all other STs. A node connection between two STs reflects a single-locus variation between them. This diagram does not show the genetic distance
between unrelated STs and clonal complexes.
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45/61), tetracycline (72.1%; 44/61), sulfonamides (60.6%; 37/
61), trimethoprim (59.0%; 36/61), and streptomycin (57.3%;
35/61) and were less frequently resistant to chloramphenicol
(36.1%; 22/61), ciprofloxacin (21.3%; 13/61), spectinomycin
(19.7.3%; 12/61), tobramycin (9.8%; 6/61), apramycin (8.2%;
5/61), and gentamicin or amikacin (4.9% each; 5/61). A few
isolates of phylogroups A (n  6), B1 (n  5), and D (n  7)
exhibited the multiresistant phenotype ACSSuTTp (indicating
resistance to ampicillin, chloramphenicol, streptomycin, sul-
fonamides, tetracycline, and trimethoprim, respectively), which
has recently been associated with a genetic island that com-
prises genes encoding antibiotic resistance and virulence in
particular E. coli clones causing UTIs (UPEC strains) (30).
Interestingly, phylogroup A and D isolates showing the
ACSSuTTp phenotype were also resistant to fluoroquinolones
(data not shown).
Our collection contained a large number of community E.
coli isolates of phylogroups A and B1, besides those of group
D, unlike the population structure of CTX-M-14-producing
isolates from other countries, which mainly comprises phylo-
groups D and B2 (23, 46, 47, 49). It is of note that the majority
of the UPEC isolates also belonged to phylogenetic groups B2
and D, with some E. coli isolates recently recognized as being
globally disseminated UPEC clones, such as ST131, ST69,
ST14, ST73, and ST95 (6, 28, 50). Even though groups A and
B1 of E. coli have rarely been involved in extraintestinal infec-
tions, they are prevalent as commensal organisms in both an-
imals and humans and are frequently found to be enterotoxi-
genic, enterohemorrhagic, and, sometimes, enteroaggregative,
with each pathotype possessing a unique combination of viru-
lence traits eventually linked to particular successful clones
(18, 24, 52, 55). The E. coli ST10 complex is overrepresented
among isolates of phylogroup A, being frequently identified
among fecal isolates from healthy people, enterotoxigenic
strains from community-based persons, and more recently,
ESBL producers causing UTIs (29, 44, 52, 55; this study).
Similarly, some group B1 E. coli clones are increasingly found
to be ST155 or ST359 and have recently been isolated from
Spanish, Portuguese, and Brazilian outpatients with UTIs (37,
55; unpublished results). These group A and B1 clones might
reflect new UPEC strains that have emerged. These strains are
independently associated with the presence of blaCTX-M-14 and
may influence the successful spread of certain ESBL genes.
Their high degree of epidemicity is also reflected by their high
rate of transmission among household contacts of patients with
UTIs (54). The selection and spread of particular STs within
these phylogroups might be influenced by the acquisition of
specific genetic traits that enhance their colonization ability
(24, 30, 50).
The blaCTX-M-14 gene is located on IncK and IncHI2 plas-
mids. The blaCTX-M-14 gene was located on plasmids exhibiting
various transfer properties (blaCTX-M-14 was transferred by
conjugation in 75.4% of the isolates) and hybridizing with
probes specific for narrow-host-range incompatibility group
IncI and/or IncK (94.9%; 37/39) and to a much lesser extent
IncHI2 (5.1%; 2/39).
Plasmids of the IncI complex. Twenty-seven of the 29 plas-
mids characterized were similar in size (80 to 90 kb), could be
amplified with primers included in the PBRT assay specific for
both the IncI and the IncK groups (but rarely with primers
specific for the IncB/O group), and hybridized with probes
specific for the inc regions of these plasmid groups. They
were classified into four types on the basis of their restric-
tion fragment length polymorphism patterns, with three of
them (pRYC105, pRYC108, and pRYC109) showing very sim-
ilar profiles that differed by only a few bands (n  1 to 3).
pRYC105 was the predominant plasmid variant and was re-
covered from inpatients, outpatients, and healthy volunteers
from 2000 to 2005. Nowadays, it is still detected in the Hospital
Universitario Ramo´n y Cajal and other geographical areas
(data not shown). pRYC105, pRYC108, and pRYC109
showed 99% to 100% sequence homology to inc_R387,
RepA_pSERB1/R387, and NikB_pSERB1/R387 (GenBank ac-
cession no. M93063 for plasmid R387 and GenBank accession
no. AY686591 for plasmid pSERB1) and were classified as
plasmids of the IncK group. The entire 1.2-kb replication re-
gion of pRYC105 (inc, repY, repA/repZ, ori) from different
isolates was sequenced and showed 99% sequence homology at
the nucleotide level with the nucleotide sequence of R387.
Nevertheless, analysis of the sequence corresponding to the
PCR product obtained with IncI-specific primers showed 99 to
100% homology with the RNAi regions of plasmids pTN38148,
pSL476_91, and pCVM29188 (GenBank accession nos.
NC_011514, NC_011077, and CP01118, respectively), which
indeed belong to the IncI group (Fig. 2 and 3). The probes
generated from the PCR products corresponding to inc_R387/
pSERB1 and inc_pSL476_91 hybridized with a single band of
PstI-digested plasmid DNA from different isolates. Although
cross hybridization can occur when these probes are used (13),
the presence of two different sequences identical to the inc
regions of plasmids belonging to the IncI and IncK groups was
demonstrated in the isolates analyzed, indicating the presence
of two different inc sequences located close together.
The fourth type, pRYC106, showed a different restriction
fragment length polymorphism pattern with sequences identi-
cal to inc_pSL476_91, RepA_pSL476_91, and NikB_pSERB1
(GenBank accession no. CP001118 for plasmid pSL476_91 and
GenBank accession no. AY686591 for plasmid pSERB1; Fig.
2) and it was considered a mosaic plasmid of the IncI complex.
Despite the multiresistance phenotypes of the E. coli hosts,
transconjugants containing these plasmids conferred resistance
only to cephalosporins (Table 2). The results of the analysis of
their DNA sequences corresponding to the RNA antisense
molecules involved in the control of replication, the replicases,
and the relaxases are shown in Fig. 2 and 3.
The plasmid analytic approach used in this work permits
not only the discrimination between IncI and IncK plasmids
but also allows the detection of recombinant plasmids con-
taining either the replication or the conjugation systems of
these groups, which seem to be frequent in nature. Some
examples are recently described plasmids pSC138 (GenBank
accession no. NC_006856) and pO113 (GenBank accession
no. NC_007365), which contain only conjugation systems re-
lated to the IncI group; pCooKm (GenBank accession no.
CR942285), which contains a replication region and a conju-
gative region related to those of the incompatibility plasmid
groups I and F, respectively; and p026-Vir (GenBank acces-
sion no. NC_012487.1), which contains two replicases homol-
ogous to different IncI plasmids and two relaxases highly sim-
ilar to those of IncK plasmids. Even though the presence of
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two inc sequences that are located close together has not
been observed among plasmids of the IncI complex, plas-
mids of incompatibility groups F and N may contain two
inc/cop sequences within the same replication region (14,
42). It is worthwhile to highlight the stability of the
pRYC105 fingerprints among different E. coli lineages over
time, which suggests a high degree of adaptation to specific
genetic backgrounds. However, the wide distribution of
pRYC105 among E. coli isolates from community-based
persons (53, 54) and food-borne animals (31) is of concern
since it creates a reservoir of highly transmissible plasmids
in heterogeneous E. coli populations that colonize different
environments which may be able to evolve toward more
virulent variants by recombination, as seems to have oc-
curred with p026-Vir (GenBank accession no.
NC_012487.1) and pCooKm (GenBank accession no.
CR942285).
IncK plasmids have been isolated from patients with UTIs
since the early 1970s (1a, 16, 21, 51). A type IV secretion
system that contributes both to plasmid conjugation and to
adherence to epithelial cells and abiotic surfaces identified
in IncK plasmids such as pSERB1 (GenBank accession no.
AY686591) (16) may facilitate the ability of E. coli to colonize
the intestine and, consequently, enhance the pathogenic pro-
file of specific clones or clonal groups (16, 43). The acquisition
of IncK plasmids containing blaCTX-M-14 by group A and B1 E.
coli clones could have enhanced their ability to colonize the
urinary tract in patients exposed to antibiotics, as highlighted
FIG. 2. (Top) Protein sequence alignment of replication proteins amplified from IncI1 and IncK plasmids. White on black, invariant amino
acids; black on dark gray, strongly conserved amino acids; black on light gray, similar amino acids; gray on white, weakly similar amino acids.
(Bottom) Phylogeny of replicases from the IncI1 and IncK plasmids. A neighbor-joining tree was constructed by using the complete deletion and
p-distance model and was tested with bootstrap values (1,000 replicates) and by use of the multiple alignments of complete replicase
sequences of several IncI1, IncK, and IncL/M plasmids by using MEGA software (version 3.1) (27). The replicase of plasmid p29930 was
used to root the tree. Replicases whose protein sequences are 100% identical to those amplified from samples of plasmids pRYC105, pRYC106,
and pRYC108 are grouped by keys. The GenBank accession numbers of the proteins used in the phylogeny are as follows: R64, NP_863360;
ColIb-P9, NP_052449; pNF1358, AAZ05341; pMU707, AAA98176; pO113, YP_308827; pSE11-1, YP_002296026; pETEC_73, YP_001451513;
pSL476_91, YP_002043842; pCVM29188_101, YP_002039041; pTN38148, YP_002302249; pS12, BAD72945; pSERB1, AAT94184; pCTX-M3,
NP_775034; pMU407.1, AAA87028; pEL60, NP_943262; p29930, CAD58558.
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by the high frequency of fluoroquinolone resistance among
CTX-M-14-producing E. coli isolates causing UTIs (65.6%).
Plasmids of the IncHI2 group. The blaCTX-M-14 gene was
located on a 290-kb transferable IncHI2 plasmid in two iso-
lates. The sequences corresponding to the replication origin
and the relaxase showed homology with R478 (GenBank acces-
sion no. BX664015.1), the prototype of the IncHI2 plasmids.
Despite the low frequency of IncHI2 plasmids in our series, the
role of this plasmid group in the spread of blaCTX-M-14 must not
be underestimated, as it has been reported worldwide, suggest-
ing that it is widespread (39).
The blaCTX-M-14 enzyme is located in different genetic plat-
forms, supporting different mobilization events. We identified
two variants of blaCTX-M-14 previously designated CTX-M-14a
(n  59/61) and CTX-M-14b (n  2/61) (GenBank accession
nos. AF252622 and DQ359215, respectively). blaCTX-M-14a is
the predominant variant described and encodes the enzyme
considered to be the progenitor of the CTX-M-9 cluster also
known as CTX-M-18 (4). To date, the blaCTX-M-14b enzyme
(GenBank accession no. EU274579) has been detected only in
Spain and Tunisia (39), and it exhibits three nucleotide
changes (A372G, G570A, G702A) in relation to the nucleotide
sequence of blaCTX-M-14a. The last two are also found in
blaCTX-M-9 (GenBank accession no. AF174129).
In our study, blaCTX-M-14a was associated with either ISEcp1
in IncK plasmids (n  27) or ISCR1 in an IncHI2 plasmid (n 
1) and IncI-like plasmids (n  3). blaCTX-M-14b was linked to
ISCR1 in an IncHI2 plasmid (n  1) or to ISEcp1 in an IncK
plasmid (pRYC109) (n  1). A truncated IS903 sequence was
identified downstream of ISEcp1-bla sequences in representa-
tive isolates corresponding to each plasmid type. ISEcp1 was
detected 42 nucleotides upstream of both blaCTX-M-14a and
blaCTX-M-14b. It is of note that an identical 42-bp region has
also been identified upstream of different genes encoding
FIG. 3. (Top) Sequence alignment of partial relaxase sequences amplified from CTX-M-14-carrying plasmids pRYC105 and pRYC108 with
oligonucleotides specific for IncI1 and IncK plasmids. White on black, invariant amino acids; black on dark gray, strongly conserved amino acids;
black on light gray, similar amino acids; gray on white, weakly similar amino acids. (Bottom) Phylogeny of clade MOBP12 relaxases from IncI1 and
IncK plasmids and an expanded view of clade MOBP12 (19). A neighbor-joining tree was constructed by using the pairwise deletion and p-distance
model and was tested with bootstrap values (1,000 replicates) and by use of the multiple alignment of the N-terminal 300 amino acids of relaxase
proteins of several IncI1, IncK, and IncL/M plasmids by using MEGA software (version 3.1) (27). Relaxase TraI of IncP1- plasmid RP4 was used
to root the tree. Black lines, branches comprising relaxases of IncI1 plasmids; gray lines, relaxases of IncK plasmids. Relaxases whose protein
sequences are 100% identical to those amplified from samples of plasmids pRYC105 and pRYC108 are grouped by keys. The GenBank accession
numbers of the plasmid relaxases used in the phylogeny are as follows: R64, BAA78021; pSL476_91, YP_002043909; ColIb-P9, NP_052501;
pNF1358, AAZ05365; pSE11-1, BAG80277; pETEC_73, YP_001451521; pCVM29188_101, YP_002039113; pSC138, YP_209402; pO113,
YP_308733; pSERB1, AAT94234; pCTX-M3, AAN87675; pEL60, NP_943241; and RP4, CAA38336.
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ESBLs of the CTX-M-9 cluster, such as CTX-M-9, -14, -16,
-17, -19, -21, and -24 and Toho-2 (GenBank accession nos.
AF174129, AF252622, AY033516, AF454633, AF458080,
AJ416346, NC_011617, and D89862, respectively), which
would indicate a unique origin for these variants, as suggested
previously (4). An integron platform similar to that of In60
which contains blaCTX-M-9 (GenBank accession no. AF174129)
and which is not linked to Tn21 was identified among the five
isolates harboring ISCR1 and blaCTX-M-14a or blaCTX-M-14b
within IncI and IncHI2 plasmids (41). The characterization of
similar genetic structures for the blaCTX-M-14 variants in this
and other studies probably reflects in-platform -lactamase
gene mutation-based evolution. This kind of presumed local
sequence evolution has been demonstrated for CTX-M
enzymes belonging to other phylogenetic clusters, such as
blaCTX-M-1 and blaCTX-M-32 or blaCTX-M-3 and blaCTX-M-15
(40).
The location of blaCTX-M-14a and blaCTX-M-14b on different
genetic platforms linked to ISEcp1 and ISCR1 on plasmids of
different incompatibility groups suggests different mobiliza-
tion events and subsequent recombinatorial processes
among plasmids.
Conclusions. The high frequency of occurrence of the
blaCTX-M-14 enzyme in our geographic area is mainly due to the
spread of IncK plasmids among UPEC clones of phylogroups
A, B1, and D, with particular STs being overrepresented. The
countrywide dissemination of this plasmid may also be sug-
gested on the basis of two Spanish studies which inferred the
presence of IncK plasmids among CTX-M-14-producing iso-
lates recovered from different cities by the amplification of
specific sequences from a few isolates by the PBRT method
(15, 39). However, data about plasmids containing blaCTX-M-14
from other countries where this ESBL is commonly detected
indicate that other incompatibility groups can also be involved
in the dissemination of CTX-M-14 (34, 54a). The diversity of
genetic platforms containing blaCTX-M-14 highlights the hy-
pothesis of the existence of different mobilization events for
this gene (4) and the influence of the genetic context on its
successful dissemination.
The results obtained by the multilevel approach used in the
present study offer an example of how different biological and
genetic entities should be simultaneously taken into consider-
ation to explain the local spread of antibiotic resistance (3).
This particular complex landscape reflects the efficient inter-
play between clonal epidemicity, plasmid transfer and mainte-
nance, the capture of resistance genes by particular genetic
platforms, and, possibly, bacterial virulence traits in determin-
ing the evolution of bacteria at the local level (35).
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